ARA-290

A synthetic peptide derived from a structural region of erythropoietin (EPO). It was designed to selectively engage the innate repair receptor (IRR) — a receptor complex distinct from the classical EPO receptor pathway responsible for erythropoiesis (red blood cell production).It is produced via peptide synthesis and supplied for use in controlled laboratory research environments.

• Characterization of peptide structural and conformational properties
• Analysis of stability, solubility, and degradation profiles under varied laboratory conditions
• Investigation of physicochemical characteristics of synthetic peptide sequences
• Method development for analytical techniques (e.g., HPLC, mass spectrometry) applied to peptide analysis
• Investigations into peripheral nerve fiber signaling and small-fiber neuropathy models
• Preclinical models of cellular stress response following ischemic or oxidative injury